IM Cannabis Corp. (IMCC)
NASDAQ: IMCC · Real-Time Price · USD
0.2840
-0.0157 (-5.24%)
At close: Apr 24, 2026, 4:00 PM EDT
0.2701
-0.0139 (-4.89%)
After-hours: Apr 24, 2026, 7:59 PM EDT
IM Cannabis Revenue
In the year 2025, IM Cannabis had annual revenue of 54.73M CAD with 1.30% growth. IM Cannabis had revenue of 15.68M in the quarter ending December 31, 2025, with 17.62% growth.
Revenue (ttm)
54.73M CAD
Revenue Growth
+1.30%
P/S Ratio
0.04
Revenue / Employee
576,116 CAD
Employees
95
Market Cap
1.77M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 54.73M | 700.00K | 1.30% |
| Dec 31, 2024 | 54.03M | 5.23M | 10.71% |
| Dec 31, 2023 | 48.80M | -5.53M | -10.18% |
| Dec 31, 2022 | 54.34M | 20.28M | 59.56% |
| Dec 31, 2021 | 34.05M | 18.16M | 114.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sunshine Biopharma | 36.31M |
| cbdMD | 19.09M |
| Universe Pharmaceuticals INC | 17.86M |
| Sonoma Pharmaceuticals | 17.72M |
| RedHill Biopharma | 9.55M |
| InMed Pharmaceuticals | 4.51M |
| China SXT Pharmaceuticals | 1.54M |
| Akanda | 836.66K |
IMCC News
- 16 days ago - IMC Announces Receipt of Nasdaq Minimum Bid Price Notification - PRNewsWire
- 26 days ago - IM Cannabis Reports 2025 Results: Revenue of C$54.7 Million with Over 134% Growth in Germany and Positive Operating Cash Flow - PRNewsWire
- 5 weeks ago - IMC Announces a Strategic Entry to the Cyber Drone Interception and Satellite Intelligence Markets by Signing a Non-Binding Agreement to Acquire 51% of Blackaxe Technologies - PRNewsWire
- 3 months ago - IM Cannabis Raises US$2,171,660.40 in Note Purchase Agreements - PRNewsWire
- 3 months ago - IM Cannabis Announces the Appointment of Mr. Alon Dayan to its Board of Directors - PRNewsWire
- 4 months ago - IM Cannabis Explores U.S. Market Entry Following President Trump's Executive Order on Increasing Medical Marijuana and Cannabidiol Research - PRNewsWire
- 4 months ago - IM Cannabis Appoints Asi Levi as Chief Financial Officer - PRNewsWire
- 5 months ago - IM Cannabis Reports Third Quarter 2025 Financial Results - PRNewsWire